Rosetta Stone to Report Fourth Quarter and Full Year 2015 Financial Results on March 14
Mar 07, 2016 21:16 pm UTC| Business
ARLINGTON, VA, March 07, 2016 -- Rosetta Stone Inc. (NYSE:RST), a world leader in technology-based learning solutions, today announced it will report its fourth quarter and full year 2015 financial results, for the...
Quanex Building Products Announces First Quarter 2016 Results and Reaffirms Full Year 2016 Guidance
Mar 07, 2016 21:15 pm UTC| Business
Margin Expansion Led by Improvement in North America Vinyl Profiles Business Significant EBITDA Contribution from HL Plastics Woodcraft Acquisitions HOUSTON, March 07, 2016 -- Quanex Building Products Corporation...
Pzena Investment Management, Inc. Announces February 29, 2016 Assets Under Management
Mar 07, 2016 21:15 pm UTC| Business
NEW YORK, March 07, 2016 -- Pzena Investment Management, Inc. (NYSE:PZN) today reported its preliminary assets under management as of February 29, 2016. AUM for month-end February 2016, month-end January 2016, and...
Ultrapetrol Announces Expansion of Board of Directors
Mar 07, 2016 21:15 pm UTC| Business
NASSAU, Bahamas, March 07, 2016 -- Ultrapetrol (Bahamas) Limited(Nasdaq:ULTR), an industrial transportation company serving marine transportation needs in three markets (River Business, Offshore Supply Business, and...
Otonomy Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Corporate Update
Mar 07, 2016 21:14 pm UTC| Business
SAN DIEGO, March 07, 2016 -- Otonomy, Inc.(NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today reported...
Nivalis Therapeutics Expands N91115 Clinical Development Program in Cystic Fibrosis
Mar 07, 2016 21:05 pm UTC| Business
Higher-dose arm initiated in ongoing Phase 2 study following safety review by independentData Monitoring Committee New Phase 2 study planned for patients who have one copy of the F508del-mutation and a second gating...
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
Mar 07, 2016 21:05 pm UTC| Business
TUSTIN, Calif., March 07, 2016 -- Peregrine Pharmaceuticals, Inc. (Nasdaq:PPHM) (Nasdaq:PPHMP) today announced that its Board of Directors has declared a quarterly cash dividend payment on the Company's 10.50% Series E...